ERCC2 and head and neck squamous cell carcinoma: We validated the quantitative reverse transcription PCR (qRT-PCR) results by immunoprobing for BRCA2, XPD and APE1 proteins in the PBL of all 106 HNSCC patients and 122 controls recruited for this study.